These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 38152335)

  • 41. Hsa_circ_0072765 knockdown inhibits proliferation, activation and migration in transforming growth factor-beta (TGF-β)-induced hepatic stellate cells (HSCs) by the miR-197-3p/TRPV3 axis.
    Jin Y; Guo X; Zhang R; Yan C
    Histol Histopathol; 2023 Nov; 38(11):1295-1306. PubMed ID: 36714978
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Geniposide inhibits hepatic fibrosis and hepatic stellate cell activation through blocking the TGF-β1/Smad signaling pathway].
    Zhou LH; Chen X
    Sheng Li Xue Bao; 2022 Apr; 74(2):217-224. PubMed ID: 35503069
    [TBL] [Abstract][Full Text] [Related]  

  • 43. lncRNA GAS5 restrains CCl
    Dong Z; Li S; Wang X; Si L; Ma R; Bao L; Bo A
    Am J Physiol Gastrointest Liver Physiol; 2019 Apr; 316(4):G539-G550. PubMed ID: 30735452
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Ligustrazine Attenuates Liver Fibrosis by Targeting miR-145 Mediated Transforming Growth Factor-
    Qiu JL; Zhang GF; Chai YN; Han XY; Zheng HT; Li XF; Duan F; Chen LY
    J Pharmacol Exp Ther; 2022 Jun; 381(3):257-265. PubMed ID: 35398813
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The miR-139-5p/peripheral myelin protein 22 axis modulates TGF-β-induced hepatic stellate cell activation and CCl
    He C; Shu B; Zhou Y; Zhang R; Yang X
    Life Sci; 2021 Jul; 276():119294. PubMed ID: 33675896
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Antifibrotic effects of luteolin on hepatic stellate cells and liver fibrosis by targeting AKT/mTOR/p70S6K and TGFβ/Smad signalling pathways.
    Li J; Li X; Xu W; Wang S; Hu Z; Zhang Q; Deng X; Wang J; Zhang J; Guo C
    Liver Int; 2015 Apr; 35(4):1222-33. PubMed ID: 25040634
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Bone morphogenetic protein-7 represses hepatic stellate cell activation and liver fibrosis
    Zou GL; Zuo S; Lu S; Hu RH; Lu YY; Yang J; Deng KS; Wu YT; Mu M; Zhu JJ; Zeng JZ; Zhang BF; Wu X; Zhao XK; Li HY
    World J Gastroenterol; 2019 Aug; 25(30):4222-4234. PubMed ID: 31435175
    [TBL] [Abstract][Full Text] [Related]  

  • 48. MicroRNA-30a ameliorates hepatic fibrosis by inhibiting Beclin1-mediated autophagy.
    Chen J; Yu Y; Li S; Liu Y; Zhou S; Cao S; Yin J; Li G
    J Cell Mol Med; 2017 Dec; 21(12):3679-3692. PubMed ID: 28766848
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Inhibitory effects of oxymatrine on hepatic stellate cells activation through TGF-β/miR-195/Smad signaling pathway.
    Song LY; Ma YT; Fang WJ; He Y; Wu JL; Zuo SR; Deng ZZ; Wang SF; Liu SK
    BMC Complement Altern Med; 2019 Jun; 19(1):138. PubMed ID: 31221141
    [TBL] [Abstract][Full Text] [Related]  

  • 50. miR-488-5p mitigates hepatic stellate cell activation and hepatic fibrosis via suppressing TET3 expression.
    Qiu J; Wu S; Wang P; Zhou Y; Wang Z; Sun Y; Jiang C
    Hepatol Int; 2023 Apr; 17(2):463-475. PubMed ID: 36001230
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Morin attenuates diethylnitrosamine-induced rat liver fibrosis and hepatic stellate cell activation by co-ordinated regulation of Hippo/Yap and TGF-β1/Smad signaling.
    Perumal N; Perumal M; Halagowder D; Sivasithamparam N
    Biochimie; 2017 Sep; 140():10-19. PubMed ID: 28552397
    [TBL] [Abstract][Full Text] [Related]  

  • 52. MicroRNA-195 Activates Hepatic Stellate Cells In Vitro by Targeting Smad7.
    Song LY; Ma YT; Wu CF; Wang CJ; Fang WJ; Liu SK
    Biomed Res Int; 2017; 2017():1945631. PubMed ID: 28929107
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Imatinib suppresses activation of hepatic stellate cells by targeting STAT3/IL-6 pathway through miR-124.
    Alavifard H; Mazhari S; Meyfour A; Tokhanbigli S; Ghavami S; Zali MR; Aghdaei HA; Hatami B; Baghaei K
    Cell Biol Int; 2023 May; 47(5):969-980. PubMed ID: 36655489
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Twist1-induced miR-199a-3p promotes liver fibrosis by suppressing caveolin-2 and activating TGF-β pathway.
    Yang X; Ma L; Wei R; Ye T; Zhou J; Wen M; Men R; Aqeilan RI; Peng Y; Yang L
    Signal Transduct Target Ther; 2020 Jun; 5(1):75. PubMed ID: 32499481
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Isorhamnetin attenuates liver fibrosis by inhibiting TGF-β/Smad signaling and relieving oxidative stress.
    Yang JH; Kim SC; Kim KM; Jang CH; Cho SS; Kim SJ; Ku SK; Cho IJ; Ki SH
    Eur J Pharmacol; 2016 Jul; 783():92-102. PubMed ID: 27151496
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Activation of primary hepatic stellate cells and liver fibrosis induced by targeting TGF-β1/Smad signaling in schistosomiasis in mice.
    Huang P; Ma H; Cao Y; Zhan T; Zhang T; Wang X; Zhang Y; Xu J; Xia C
    Parasit Vectors; 2022 Dec; 15(1):456. PubMed ID: 36474240
    [TBL] [Abstract][Full Text] [Related]  

  • 57. MicroRNA-101 suppresses liver fibrosis by targeting the TGFβ signalling pathway.
    Tu X; Zhang H; Zhang J; Zhao S; Zheng X; Zhang Z; Zhu J; Chen J; Dong L; Zang Y; Zhang J
    J Pathol; 2014 Sep; 234(1):46-59. PubMed ID: 24817606
    [TBL] [Abstract][Full Text] [Related]  

  • 58. miR-455-3p Alleviates Hepatic Stellate Cell Activation and Liver Fibrosis by Suppressing HSF1 Expression.
    Wei S; Wang Q; Zhou H; Qiu J; Li C; Shi C; Zhou S; Liu R; Lu L
    Mol Ther Nucleic Acids; 2019 Jun; 16():758-769. PubMed ID: 31150929
    [TBL] [Abstract][Full Text] [Related]  

  • 59. MicroRNA-17-5p activates hepatic stellate cells through targeting of Smad7.
    Yu F; Guo Y; Chen B; Dong P; Zheng J
    Lab Invest; 2015 Jul; 95(7):781-9. PubMed ID: 25915722
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Blockade of YAP alleviates hepatic fibrosis through accelerating apoptosis and reversion of activated hepatic stellate cells.
    Yu HX; Yao Y; Bu FT; Chen Y; Wu YT; Yang Y; Chen X; Zhu Y; Wang Q; Pan XY; Meng XM; Huang C; Li J
    Mol Immunol; 2019 Mar; 107():29-40. PubMed ID: 30639476
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.